Page last updated: 2024-09-02
2-hydroxyimipramine and ziprasidone
2-hydroxyimipramine has been researched along with ziprasidone in 2 studies
Compound Research Comparison
Studies (2-hydroxyimipramine) | Trials (2-hydroxyimipramine) | Recent Studies (post-2010) (2-hydroxyimipramine) | Studies (ziprasidone) | Trials (ziprasidone) | Recent Studies (post-2010) (ziprasidone) |
---|---|---|---|---|---|
30 | 3 | 0 | 1,068 | 254 | 362 |
Protein Interaction Comparison
Protein | Taxonomy | 2-hydroxyimipramine (IC50) | ziprasidone (IC50) |
---|---|---|---|
D(2) dopamine receptor | Homo sapiens (human) | 0.005 | |
Aspartate aminotransferase, cytoplasmic | Homo sapiens (human) | 5.39 | |
D | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1514 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.011 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0004 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.011 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.011 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.2301 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Other Studies
2 other study(ies) available for 2-hydroxyimipramine and ziprasidone
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |